11:01:38 EDT Tue 22 Sep 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Cannabis Summary for Dec. 18, 2019

2019-12-18 20:32 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The Canadian Securities Exchange Composite Index lost 5.46 points to 361.57 Wednesday. Health Canada issued a release yesterday announcing that Zenabis Global Inc. (ZENA: $0.18) recalled its Namaste CBD Light capsules. The capsules, which are labelled as containing 6.13 milligrams of CBD and a minuscule 0.19 mg of THC, were recalled after it was determined that they had been incorrectly labelled. Instead of the advertised doses on the bottle, the capsules did not contain any CBD and instead had 2.247 mg of THC. For context, under Health Canada regulations, the maximum allowable amount of THC per capsule is 10 mg. Since THC is the part of marijuana that gets you "high," some customers could have been in for a rude surprise. However, the 2.247 mg THC is still small enough an amount that it would not have had a significant effect. The company received one complaint on the product and Health Canada did not receive any. Zenabis sold 165 units (each unit has 15 capsules) of the recalled product.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2020 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.